BOLIGNANO, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 3.900
NA - Nord America 3.389
AS - Asia 1.773
SA - Sud America 576
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.688
Nazione #
US - Stati Uniti d'America 3.330
RU - Federazione Russa 2.011
SG - Singapore 751
CN - Cina 543
SE - Svezia 540
BR - Brasile 513
IE - Irlanda 492
DE - Germania 220
HK - Hong Kong 196
FR - Francia 135
UA - Ucraina 123
FI - Finlandia 108
VN - Vietnam 93
GB - Regno Unito 89
IT - Italia 83
IN - India 51
AR - Argentina 28
CA - Canada 27
PL - Polonia 22
BD - Bangladesh 21
JP - Giappone 18
MX - Messico 17
TR - Turchia 15
ZA - Sudafrica 15
CZ - Repubblica Ceca 14
IQ - Iraq 14
ES - Italia 13
BE - Belgio 11
MA - Marocco 11
ID - Indonesia 10
AT - Austria 9
EC - Ecuador 9
VE - Venezuela 9
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
LV - Lettonia 6
CO - Colombia 5
PK - Pakistan 5
TN - Tunisia 5
AZ - Azerbaigian 4
DK - Danimarca 4
EG - Egitto 4
GY - Guiana 4
KE - Kenya 4
NL - Olanda 4
NP - Nepal 4
OM - Oman 4
UZ - Uzbekistan 4
AL - Albania 3
CH - Svizzera 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
NI - Nicaragua 3
NO - Norvegia 3
PH - Filippine 3
PS - Palestinian Territory 3
PY - Paraguay 3
SN - Senegal 3
UY - Uruguay 3
BH - Bahrain 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
HN - Honduras 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
MD - Moldavia 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
DZ - Algeria 1
GT - Guatemala 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
ME - Montenegro 1
MN - Mongolia 1
MY - Malesia 1
PA - Panama 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TW - Taiwan 1
Totale 9.688
Città #
Ashburn 530
Moscow 526
Chandler 499
Dublin 491
Singapore 419
Dallas 325
Jacksonville 282
Nyköping 251
Beijing 215
Hong Kong 196
San Jose 124
The Dalles 122
Dearborn 90
Los Angeles 85
Princeton 73
Cambridge 69
Lauterbourg 68
Medford 64
Munich 64
New York 62
Des Moines 56
Ann Arbor 50
Boardman 50
Ho Chi Minh City 34
São Paulo 33
Buffalo 32
Helsinki 27
Bremen 25
Frankfurt am Main 25
Lancaster 22
Hanoi 20
San Mateo 20
Tianjin 20
Woodbridge 19
Jinan 18
Tokyo 17
Guangzhou 16
Orem 16
Seattle 16
Shanghai 16
Warsaw 16
Wilmington 16
Belo Horizonte 15
Redondo Beach 15
Santa Clara 15
Turku 15
Pune 13
Brooklyn 12
Chennai 12
Nanjing 12
Brussels 11
Düsseldorf 11
Houston 11
Brasília 10
Chicago 10
Porto Alegre 10
Rio de Janeiro 10
Shenyang 10
Atlanta 9
Curitiba 9
Denver 9
Haikou 9
Hebei 9
Johannesburg 9
Montreal 9
Ningbo 9
Augusta 8
Bexley 8
Boston 8
Brno 8
Dhaka 8
Rome 8
Stockholm 8
Falls Church 7
Hyderabad 7
Nanchang 7
Tappahannock 7
Jiaxing 6
Leawood 6
London 6
Manchester 6
Mexico City 6
Recife 6
Riga 6
Washington 6
Baghdad 5
Campinas 5
Carapicuíba 5
Charlotte 5
Manaus 5
Norwalk 5
Olomouc 5
Portsmouth 5
San Francisco 5
Shenzhen 5
Toronto 5
Zhengzhou 5
Baku 4
Blumenau 4
Buenos Aires 4
Totale 5.587
Nome #
Both IL-1β and TNF-α Regulate NGALExpression in Polymorphonuclear Granulocytes ofChronic Hemodialysis Patients 221
A brief "update" on renal effects of caffeine 207
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 202
Dialysis and the Elderly: An Underestimated Problem. 193
Down with the erythropoietin. Long live the erythropoietin! 184
[Erythropoietin: pleiotropic actions]. 179
Caffeine and the kidney: What evidence right now? 178
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 178
A new therapy for kidney injury: regeneration. 174
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 174
Acute cardiovascular complications of hemodialysis. 173
Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. 168
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 167
Effects of haemodialysis on circulating endothelial progenitor cell count 167
Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus 165
The erythropoietin and regenerative medicine: a lesson from fish 164
Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life. 164
Cold pressor test stimulates the mobilization of endothelial progenitor cells in hypertensive and uremic patients 159
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 157
Aquaretic agents: What's beyond the treatment of hyponatremia? 156
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools. 156
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 154
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 153
Aquaretic-induced apoptosis: a cure or a curse? 148
Erythropoietin and its lost receptor [8] 147
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 147
Malnutrition in the elderly patient on dialysis. 144
Neurobiological model and quality of life in discovering personality of the uremic patient. 143
Renal complications in oncohematologic patients. 143
Therapy with vasopressin receptor antagonists: the aquaretics 143
Erythropoietin and its lost receptor. 142
Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: An updated systematic review and meta-analysis 139
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. 137
Regenerative medicine: does Erythropoietin have a role? 137
Pregnancy in uremic patients: An eventful journey 136
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide. 136
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 134
Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis 134
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 134
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. 130
Neutrophilgelatinase-associatedlipocalin(NGAL); un biomarker oltre i confini della nefrologia 128
Erythropoietin and cancer: an old risk. 128
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. 127
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? 126
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease 124
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus 124
Il Cold Pressor Test stimola la mobilizzazione di cellule staminali ad indirizzo endoteliale nei soggetti ipertesi ed uremici 123
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients 116
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function 115
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. 115
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 114
NGAL is a precocious marker of therapeutic response. 113
Experimental therapies in renal replacement: The effect of two different potassium acetate-free biofiltration protocols on striated muscle fibers 113
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine 110
Genomic damage in endothelial progenitor cells from uremic patients. 102
Obestatin: a new element for mineral metabolism and inflammation in patients on hemodialysis. 102
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 102
Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. 100
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. 99
Pulmonary hypertension and erythropoietin. 98
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 98
Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade. 92
Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: An observational retrospective cohort study 89
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 88
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives 85
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. 85
Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. 78
NGAL: a new missing link between inflammation and uremic anemia? 75
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 74
Neutrophil gelatinase-associated lipocalin in the intensive care unit: time to look beyond a single, threshold-based measurement? 65
Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir 63
Neutrophil gelatinase-associated lipocalin levels in patients with crohn disease undergoing treatment with infliximab. 63
Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. 39
null 39
null 30
null 16
Totale 9.725
Categoria #
all - tutte 31.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.324


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021126 0 0 0 0 0 0 0 0 0 39 57 30
2021/2022544 2 73 5 19 32 4 26 17 3 120 76 167
2022/20231.563 134 169 75 144 124 152 9 94 609 7 31 15
2023/2024326 31 50 14 32 27 98 2 21 0 14 5 32
2024/20251.543 24 14 53 99 43 62 35 296 393 120 150 254
2025/20264.506 277 334 345 265 388 957 610 608 596 126 0 0
Totale 9.725